
DUNS100 2018 – Intellectual Property
We’re proud to anounce yet another esteemed national ranking guide (DUNS100 2018 – Intellectual Property) that chose DWO as on of the top Intellectual Property firms in Israel.
We’re proud to anounce yet another esteemed national ranking guide (DUNS100 2018 – Intellectual Property) that chose DWO as on of the top Intellectual Property firms in Israel.
We’re proud to anounce yet another esteemed international ranking guide (IP Stars 2018 – Patents) that chose DWO as on of the top Patent firms in Israel.
The dispute’s core are noise-canceling patents registered by Bose and allegedly infringed by Beats, on 25th of July Bose filed a suit against Beats Electronics. The axis of Bose’s claim are 50 years of research and development that the company
Ever walked and texted simultaneously? This article is about you. Apple secured a U.S patent for a so called “transparent texting” technology that enables the users to see what is in front of them while texting. Numbers of smartphone users
Amazon had secured a patent known as “method and system for anticipatory package shipping” in year 2013. The invention is basically a shipping booster which predicts pre designated area segments of proffered ordered products and pre-delivers those products to the
“Intrusive Technology” has been debated for several years now that technology minimized itself more and more. Google as the usher of new technology and pioneer of various fields of technology as filed a patent application with the USPTO. The patent
In a court ruling of Alice Corp vs. CLS Bank, the supreme court of justice hereinafter: “The Court” determined that the defense of patent eligibility shall not be bestowed upon a computed method of financial exchange which minimizes risk of
This is a fascinating story of a combination between medicine and intellectual property. The case of “Association of Molecular Pathology (AMP) v. Myriad Genetics” was discussed in several courts in the United States until the supreme court of justice, hereinafter:
The case at hand was brought by Celltrion, Inc. and Perrigo Israel Pharmaceutical, Ltd. against Genentech, Inc., owner of the disputed patent, regarding Patent Cancellation Request No. 122910. The case was brought before Yearah Shoshani-Caspi, arbiter, of the Israeli Patent